Evidence map›Paper›PMID 30760244›Full record

ArticleBMC pulmonary medicine2019

NK and NKT cells in the diagnosis of diffuse lung diseases presenting with a lymphocytic alveolitis.

Oksana Sokhatska, Eva Padrão, Bernardo Sousa-Pinto, Marília Beltrão, Patrícia Caetano Mota, Natália Melo, Luís Delgado, António Morais

Open access · goldAbstract read
In one paragraph

Article in BMC pulmonary medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Guideline
  2. Specific Biomarkers Involved in Sarcoidosis Diagnosis and Prognosis.International journal of molecular sciences · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. BALF and BLOOD NK- cells in different stages of pulmonary sarcoidosis.Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG · 2022
    Article
  8. Review
  9. Article
  10. Article
  11. Cytokine gene polymorphisms in Pigeon Breeder's Disease expression.Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG · 2020
    Article
  12. Article
  13. NK Cells in the Human Lungs.Frontiers in immunology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Oksana SokhatskaBasic & Clinical Immunology Unit, Department of Pathology, Faculty of Medicine, Alameda Professor Hernâni Monteiro, University of Porto, 4200-319, Porto, Portugal. o.sokhatska@gmail.com.ORCID http://orcid.org/0000-0003-3061-8066
Eva PadrãoDepartment of Pulmonology, Hospital de São João and Faculty of Medicine, University of Porto, Porto, Portugal.
Bernardo Sousa-PintoBasic & Clinical Immunology Unit, Department of Pathology, Faculty of Medicine, Alameda Professor Hernâni Monteiro, University of Porto, 4200-319, Porto, Portugal.
Marília BeltrãoBasic & Clinical Immunology Unit, Department of Pathology, Faculty of Medicine, Alameda Professor Hernâni Monteiro, University of Porto, 4200-319, Porto, Portugal.
Patrícia Caetano MotaDepartment of Pulmonology, Hospital de São João and Faculty of Medicine, University of Porto, Porto, Portugal.
Natália MeloDepartment of Pulmonology, Hospital de São João and Faculty of Medicine, University of Porto, Porto, Portugal.
Luís DelgadoBasic & Clinical Immunology Unit, Department of Pathology, Faculty of Medicine, Alameda Professor Hernâni Monteiro, University of Porto, 4200-319, Porto, Portugal.
António MoraisDepartment of Pulmonology, Hospital de São João and Faculty of Medicine, University of Porto, Porto, Portugal.
Universidade do Porto · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDiffuse lung diseases (DLD) are characterized by different immunophenotypes in the bronchoalveolar lavage fluid (BALF). We aimed to evaluate the diagnostic value of BALF NK and NKT cell counts of patients with DLD and lymphocytic alveolitis.

methodsWe assessed 202 patients with DLD, who underwent BALF immunophenotyping. Samples were routinely processed by flow cytometry and lymphocyte subsets were compared between patients with sarcoidosis (n = 106), hypersensitivity pneumonitis (HP; n = 53), and other DLDs (n = 43). We compared absolute counts and percentages of NK and NKT cells between patients with HP versus the remaining DLD patients. To assess the accuracy of BALF lymphocyte subsets in the diagnosis of HP, we calculated the respective areas under the receiver operating characteristic curves (AUC-ROC).

resultsPatients with HP had significantly higher numbers of BALF NK cells, and its percentage was significantly associated with a higher odds of HP, even after adjustment for the NKT and CD8

conclusionsBALF NK immunophenotyping may be a helpful adjunct to the diagnostic work-up of DLD, particularly in the differential diagnosis of HP.

Indexed as

AdultAgedAlveolitis, Extrinsic AllergicArea Under CurveBronchoalveolar Lavage FluidCD8-Positive T-LymphocytesFemaleFlow CytometryHumansImmunophenotypingKiller Cells, NaturalLogistic ModelsLung Diseases, InterstitialLymphocyte CountMaleMiddle AgedBronchoalveolar lavage fluidDiffuse lung diseasesHypersensitivity pneumonitisNatural killer cellsNKT cellsSarcoidosis

Identifiers

PMID30760244
PMCPMC6373142
OpenAlexW2911345295

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.